Williams Jones & Associates’s G1 Therapeutics, Inc. Common Stock GTHX Stock Holding History

Williams Jones & Associates’s Portfolio GTHX Stock Details GTHX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	$4.77M	Buy	+155,685	New	+$3.28M	0.1%	113

Other funds holding GTHX

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Williams Jones & Associates's GTHX Position: Q2 2019 in Review

Williams Jones & Associates opened a new position in G1 Therapeutics, Inc. Common Stock (GTHX) in Q2 2019: 155,685 shares worth $4.77M. The stake represents 0.1% of the portfolio and ranks #113 among its holdings.

94 funds tracked by Wall St. Rank hold GTHX as of Q2 2019.

Williams Jones & Associates held 155,685 shares of G1 Therapeutics, Inc. Common Stock worth $4.77M as of Q2 2019.
G1 Therapeutics, Inc. Common Stock was a new Williams Jones & Associates position in Q2 2019.
G1 Therapeutics, Inc. Common Stock made up 0.1% of Williams Jones & Associates's portfolio in Q2 2019, its #113 holding.
94 funds tracked by Wall St. Rank held G1 Therapeutics, Inc. Common Stock as of Q2 2019.

Based on Williams Jones & Associates's 13F filing for Q2 2019, filed 14 Aug 2019.